Drug Shortage Report for NALOXONE HCL INJECTION - 0.4MG/ML USP

Last updated on 2019-07-08 History
Report ID 80570
Drug Identification Number 02148706
Brand name NALOXONE HCL INJECTION - 0.4MG/ML USP
Common or Proper name NALOXONE HCl Inj
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1X10ml
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-04-05
Estimated end date 2019-07-08
Actual end date 2019-06-19
Shortage status Resolved
Updated date 2019-07-08
Company comments Limited inventory is currently available for this product at Sandoz. To maintain our inventory levels and to avoid unanticipated bulk orders, the product will be placed on protective allocation at 150% of historical monthly volumes until return date.
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2019-07-08 French Compare
v11 2019-07-08 English Compare
v10 2019-06-12 French Compare
v9 2019-06-12 English Compare
v8 2019-04-12 English Compare
v7 2019-04-12 French Compare
v6 2019-04-12 English Compare
v5 2019-04-11 French Compare
v4 2019-04-11 English Compare
v3 2019-04-06 English Compare
v2 2019-04-05 French Compare
v1 2019-04-05 English Compare